<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000513078"><TermName>Innohep</TermName><TermPronunciation>(IH-noh-HEP)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used with another drug, warfarin, to treat blood clots that form deep in the veins and to prevent new blood clots from forming. It is a type of anticoagulant. Also called tinzaparin and tinzaparin sodium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718492" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Innohep&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718491" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Innohep&quot;" language="es" id="_4"/><SpanishTermName>Innohep</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa con otro medicamento llamado warfarina, para tratar los coágulos de sangre que se forman en lo profundo de las venas y para prevenir que se formen nuevos coágulos de sangre. Es un tipo de anticoagulante. También se llama tinzaparina y tinzaparina sódica.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-21</DateFirstPublished><DateLastModified>2007-06-18</DateLastModified></GlossaryTerm>
